Topical 5-FU reduces CIN recurrence.
D000282:Administration, Intravaginal; D000287:Administration, Topical; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage*; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence; D002578:Uterine Cervical Dysplasia / Q000209:etiology / Q000517:prevention & control*
D000970:Antineoplastic Agents; D005472:Fluorouracil